Pharmacyte biotech, Inc., formerly Nuvilex, Inc. is a clinical-stage biotechnology company. The Company focuses on developing and preparing to commercialize treatments for cancer and diabetes based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Company uses this technology as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are developed. The Company's treatment for pancreatic cancer involves encapsulating modified live cells capable of converting the prodrug ifosfamide into its active or cancer-killing form. The Company is also engaged in developing treatments for cancer-based upon chemical constituents of the Cannabis plant, known as cannabinoids. In addition to developing treatments for pancreatic and other solid tumor cancers, it is developing a treatment for Type I diabetes and Type II insulin-dependent diabetes.